Clopra and Cayston drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clopra (metoclopramide hydrochloride) and Cayston (aztreonam). Common drug interactions include fatigue among females and infective pulmonary exacerbation of cystic fibrosis among males.

The phase IV clinical study analyzes what interactions people have when they take Clopra and Cayston. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Clopra?

Clopra has active ingredients of metoclopramide hydrochloride. eHealthMe is studying from 81,430 Clopra users. Check the latest studies of Clopra.

What is Cayston?

Cayston has active ingredients of aztreonam. It is often used in cystic fibrosis. eHealthMe is studying from 5,310 Cayston users. Check the latest studies of Cayston.

On Jul, 07, 2026

24 people who take Clopra and Cayston together, and have interactions are studied.

What are the common drug interactions of Clopra and Cayston, by gender? *:

female:

Fatigue (feeling of tiredness)
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Somnolence (a state of near-sleep, a strong desire for sleep)
Asthenia (weakness)
Back pain
Constipation
Decreased appetite

male:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Dyspnoea (difficult or laboured respiration)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Night sweats (sweating in night)
Productive cough
Pruritus (severe itching of the skin)
Pseudomonas test positive
Pyrexia (fever)
Secretion discharge
Sputum discoloured

What are the common drug interactions of Clopra and Cayston, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Bronchopulmonary aspergillosis allergic (allergic lung disorder caused by aspergillus fungi)
Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
Fatigue (feeling of tiredness)
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Somnolence (a state of near-sleep, a strong desire for sleep)

20-29:

Abdominal pain upper
Chest discomfort
Cough
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Flatulence (flatus expelled through the anus)
Headache (pain in head)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Lung disorder (lung disease)
Pneumonia

30-39:

Asthenia (weakness)
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Headache (pain in head)
Chest discomfort
Chest pain
Cough
Diarrhoea
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)

40-49:

Pulmonary hypertension (increase in blood pressure in the lung artery)
Respiration (transport of oxygen from the outside air to the cells within tissues)
Right ventricular failure (right half of the heart fails to work)
Weight decreased
Bronchial secretion retention
Decreased appetite
Dyspnoea (difficult or laboured respiration)
Haemoglobin decreased
Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Oxygen saturation decreased

50-59:

n/a

60+:

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Cough: 8 people, 33.33%
Wheezing (a high-pitched whistling sound made while you breath): 7 people, 29.17%
Constipation: 7 people, 29.17%
Cystic Fibrosis Lung (fibrosis with cyst in the lung): 7 people, 29.17%
Muscle Spasms (muscle contraction): 6 people, 25.00%
Bacterial Infection: 6 people, 25.00%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 6 people, 25.00%
Cystic Fibrosis Pancreatic (fibrosis with cyst in the pancreas): 6 people, 25.00%
Depression: 6 people, 25.00%
Faeces Hard: 6 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clopra and Cayston?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously